Upcoming Virtual and In-Person Educational Events for Patients and Medical Professionals ➜ VIEW NOW

Learn about tick-borne illness, how it can become chronic, the challenges with traditional treatment options, and how patients can begin healing.

Understanding Borrelia Miyamotoi

by Dr. Jamie Kunkle

About Borrelia miyamotoi

First identified in ticks in Japan (1994), this infection has since been detected across the globe, including Europe, Asia, and North America.

Levels have been particularly high in the North East United States, but cases in California have recently been on the rise.

Although it is classified in the Tickborne Relapsing Fever (TBRF) group, Borrelia miyamotoi often shows more similarities to classic Lyme. It is known to persist through even robust treatments and there has been evidence of this organism found in patients labeled Post Treatment Lyme Disease Syndrome (PTLDS).

Common Symptoms of Borrelia miyamotoi

  • Fevers with flu-like symptoms such as body aches, chills, shortness of breath, fatigue, brain fog, and dizziness/lightheadedness
  • Neurologic symptoms especially persistent chronic fatigue, brain fog, severe headaches, dizziness, confusion, and vertigo
  • Skin rash
  • Gut symptoms including nausea, abdominal pain, diarrhea, and anorexia
  • Autonomic dysregulation or POTS (postural orthostatic tachycardia syndrome)
  • Abnormalities in blood labs (thrombocytopenia/low platelets, monocytosis/high monocytes)

Visit the Gordon Medical Lyme Hub to learn more about Lyme Disease, co-infections, and concurrent infections.

 Lyme Hub Home